Inogen Inc (NAS:INGN)
$ 8.43 0 (0%) Market Cap: 200.79 Mil Enterprise Value: 100.27 Mil PE Ratio: 0 PB Ratio: 1.08 GF Score: 79/100

Inogen Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2022 / 03:30PM GMT
Release Date Price: $31.47 (+1.19%)
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst

Welcome. I'm Robbie Marcus, the med tech analyst at JPMorgan. Very happy to introduce Nabil Shabshab, the CEO of Inogen. Just a reminder, some housekeeping, feel free to send me any questions I can ask in Q&A. Otherwise, Nabil, I'm going to turn it over to you, and I'll join you in a few minutes.

Nabil Shabshab
Inogen, Inc. - CEO, President & Director

Thank you, Robbie. It's a pleasure to be here, and thank you for inviting us. So we're just going to forward to the slide with the forward-looking statement, just pause for 10 seconds guys, just to make sure that everybody has a chance to look at it. So if you can hit escape and just use the down button. Yes, perfect. Just let's pause for 10 seconds before we kick off.

Okay. So let's get started, guys. Again, Good morning. For those of you who might not be very familiar with Inogen, we are a medical technology company that is a global leader in portable oxygen therapy solutions. Our products are sold in 60 countries

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot